After vascular injury, repair is restricted in the presence of FSAP (right) to prevent narrowing of the blood vessel.
Approximately 5% of the population carries an FSAP polymorphism linked to cardiovascular disease. The authors' previous in vitro evidence suggested that wild-type FSAP, a plasma protein, limits vessel repair processes in part by inactivating PDGF-BB—a growth factor which promotes the proliferation and migration of blood vessel wall cells during repair.
The team isolated and characterized the mutated form of FSAP and discovered that although its ability to bind PDGF-BB was unaltered, it failed to cleave the protein efficiently....
The Rockefeller University Press
2006
The Rockefeller University Press
2006
You do not currently have access to this content.